1 Seoane J (2008) The TGFBeta pathway as a therapeutic target in cancer. Clin Transl Oncol 10: 14-19.
2 Rodon Ahnert J (2011) First Human Dose (FHD) study of the oral Trans- forming Growth Factor B (TGFB) receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma. J Clin Oncolo (suppl) abstr 3011.
3 Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19: 2783-2810.
4 Massague J (2008) TGFbeta in Cancer. Cell 134: 215-230.
5 Massague J (2012) TGFbeta signalling in context. Nat Rev Mol Cell Biol 13: 616-630.
6 Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, et al. (1997) Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89.
7Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, et al. (2000) OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP- Smad and Olf signaling pathways. Cell 100: 229-240.
8 Seoane J, Le HV, Shen L, Anderson SA, Massague J, et al. (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblas- toma cell proliferation. Cell 117: 211-223.
9 Xi Q, Wang Z, Zaromytidou AI, Zhang XH, Chow-Tsang LF, et al. (2011) A poised chromatin platform for TGF-beta access to master regulators. Cell 147: 1511-1524.
10Lin X, Duan X, Liang YY, Su Y, Wrighton KH, et al. (2006) PPM1A func- tions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125: 915-928.
11 Aggarwal K, Massague J (2012) Ubiquitin removal in the TGF-beta path- way. Nat Cell Biol 14: 656-657.
12 Izz L, Attisano L (2006) Ubiquitin-dependent regulation of TGF beta sign- aling in cancer. Neoplasia 8: 677-688.
13De Boeck M, Ten Dijke P (2012) Key role for ubiquitin protein modifica- tion in TGF beta signal transduction. Ups J Med Sci 117: 153-165.
14Clague MJ, Coulson JM, Urbe S (2012) Cellular functions of the DUBs. J Cell Sci 125: 277-286.
15 Rotin D, Kumar S (2009) Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 10: 398-409.
16 Budhidarmo R, Nakatani Y, Day CL (2012) RINGs hold the key to ubiq- uitin transfer. Trends Biochem Sci 37: 58-65.
17Kulathu Y, Komander D (2012) Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat Rev Mol Cell Biol 13: 508-523.
18 Hershko A, Ciechanover A (1998) The ubiquitin system. Annu Rev Biochem 67: 425-479.
19 Chen ZJ, Sun LJ (2009) Nonproteolytic functions of ubiquitin in cell sign- aling. Mol Cell 33: 275-286.
20Wickliffe KE, Williamson A, Meyer HJ, Kelly A, Rape M (2011) K11- linked ubiquitin chains as novel regulators of cell division. Trends Cell Biol 21: 656-663.
21 Chen HI, Sudol M (1995) The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc Natl Acad Sci U S A 92: 7819-7823.
22 Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern for- mation. Nature 400: 687-693.
23Lin X, Liang M, Feng XH (2000) Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor- beta signaling. J Biol Chem 275: 36818-36822.
24Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, et al. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375.
25 Wiesner S, Ogunjimi AA, Wang HR, Rotin D, Sicheri F, et al. (2007) Auto- inhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain. Cell 130: 651-662.
26 Tang LY, Yamashita M, Coussens NP, Tang Y, Wang X, et al. (2011) Abla- tion of Smurf2 reveals an inhibition in TGF-beta signalling through multiple mono-ubiquitination of Smad3. EMBO J 30: 4777-4789.
27 Maspero E, Valentini E, Mari S, Cecatiello V, Soffientini P, et al. (2013) Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. Nat Struct Mol Biol 20: 696-701.
28Gao S, Alarcón C, Sapkota G, Rahman S, Chen PY, et al. (2009) Ubiqui- tin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell 36: 457-468.
29Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, et al. (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139: 757-769.
30 Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, et al. (2007) Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J Biol Chem 282: 20492-20501.
31 Koinuma D, Shinozaki M, Komuro A, Goto K, Saitoh M, et al. (2003) Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J 22: 6458-6470.
32Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, et al. (2001) TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3: 587-595.
33 Mizutani A, Saitoh M, Imamura T, Miyazawa K, Miyazono K, et al. (2010) Arkadia complexes with clathrin adaptor AP2 and regulates EGF signalling. J Biochem 148: 733-741.
34 Bai Y, Yang C, Hu K, Elly C, Liu YC, et al. (2004) Itch E3 ligase-mediated regulation of TGF-beta signaling by modulating smad2 phosphorylation. Mol Cell 15: 825-831.
35 Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, et al. (2009) FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signal- ing, controls Smad4 monoubiquitination. Cell 136: 123-135.
36 Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, et al. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123: 773-786.
37 Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, et al. (2005) Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121: 87-99.
38 Komander D, Clague MJ, Urbe S (2009) Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10: 550-563.
39 Zhang L, Zhou F, Drabsch Y, Gao R, Snaar-Jagalska BE, et al. (2012) USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-beta type I receptor. Nat Cell Biol 14: 717-726.
40 Al-Salihi MA, Herhaus L, Macartney T, Sapkota GP, et al. (2012) USP11 augments TGFbeta signalling by deubiquitylating ALK5. Open Biol 2: 120063.
41 Eichhorn PJ, Rodon L, Gonzalez-Junca A, Dirac A, Gili M, et al. (2012) USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma. Nat Med 18: 429-435.
42 Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, et al. (2005) The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24: 8080-8084.
43 Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, et al. (2011) USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol 13: 1368-1375.
44 Itoh F, Asao H, Sugamura K, Heldin CH, ten Dijke P, et al. (2001) Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J 20: 4132-4142.
45 Hurley JH (2011) Nipped in the bud: how the AMSH MIT domain helps deubiquitinate lysosome-bound cargo. Structure 19: 1033-1035.
46 Lee BH, Lee MJ, Park S, Oh DC, Elsasser S, et al. (2010) Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467: 179-184.